BioPharmX
researches, develops and commercializes novel prescription products for pharmaceutical and women’s health markets... Read moreBioPharmX
researches, develops and commercializes novel prescription products for pharmaceutical and women’s health markets... Read more
News
May 20, 2020
NJBIZ
BioPharmX: Drugmakers close merger, secure $25M financing
May 15, 2020
BioSpace
BioPharmX: BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020
May 13, 2020
BioSpace
BioPharmX: BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting
May 12, 2020
Seeking Alpha
BioPharmX: BioPharmX shareholders back tie-up with Timber Pharmaceuticals
Apr 27, 2020
BioSpace
BioPharmX: BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 AM eastern time
Apr 27, 2020
PR Newswire
Press Release: BioPharmX : BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 AM eastern time
Mar 24, 2020
BioSpace
BioPharmX: BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain Trading
Mar 02, 2020
centralcharts
Press Release: BioPharmX : BioPharmX Corporation - BPMX Stock Chart Technical Analysis for 03-02-2020
Jan 30, 2020
centralcharts
Press Release: BioPharmX : BioPharmX Corporation - BPMX Stock Chart Technical Analysis for 01-30-2020
Jan 29, 2020
The Pharma Letter
BioPharmX: Timber takes reverse IPO route to fund orphan dermatology candidates
